Literature DB >> 18638780

The Guglielmi coil for transarterial occlusion of intracranial aneurysm: preliminary Western Australian experience.

T Apsimon1, M Khangure, J Ives, B Stokes, M Lee, G Wayne-Thomas, G Wong, P Watson.   

Abstract

18 patients aged 3-75 years with cranial arterial aneuryms have been treated by transarterial insertion of Guglielmi Detachable Coils (GDC). 11 patients had previously bled and 9 pts had previous craniotomy for the same aneurysm. 22 technically successful procedures were performed in 17 aneurysms (16 patients). Subsequent repacking was performed 8 times (5 patients). There were 4 unsuccessful procedures in 2 patients. Including repackings, 9 aneurysms (8 patients) show complete occlusion and 7 aneurysms are considered stable with either a neck remnant or persistent partial filling of the aneurysm. 1 aneurysm showed repeated recanalisation necessitating multiple repackings. 1 patient developed recanalisation, aneurysm enlargement and died of recurrent subarachnoid haemorrhage (SAH) at 7 months. 8 patients suffered procedural complications or deficits. 3 patients showed occlusion of a parent artery. On 6-18 month follow up 13 survivors are well and symptom free and 1 has recovered mild hemiparesis. Three recent patients are progressing well but await follow up. Our results are compared with a larger series reported from the North American GDC trial.

Entities:  

Year:  1995        PMID: 18638780     DOI: 10.1016/0967-5868(95)90026-8

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  2 in total

1.  The role of endovascular treatment in unruptured basilar tip aneurysms.

Authors:  Huijian Ge; Xianli Lv; Hengwei Jin; Zhihua Tian; Youxiang Li; Hongwei He
Journal:  Interv Neuroradiol       Date:  2016-09-22       Impact factor: 1.610

2.  Endovascular minimally invasive treatment of the intracranial aneurysms--first 124 cases.

Authors:  S Dima; C Scheau; F Stefanescu; L Danaila
Journal:  J Med Life       Date:  2012-09-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.